BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 15, 1999
View Archived Issues
Alexion commences phase IIb trial of C5 inhibitor for bypass surgery
Read More
Icos reviews recent developments at H&Q; new addition to pipeline revealed
Read More
Pharmacokinetic studies support safety of novel dental agent
Read More
North American Vaccine updates development pipeline at H&Q
Read More
Novel compounds developed at Roche for lipid disorders and fungal infections
Read More
Cardioprotective benzoylguanidines with improved properties claimed by Hoechst
Read More
Indole-based antimigraine agents in development at Allelix
Read More
Urea derivatives acting at multiple 5-HT receptor subtypes emerge from SB R&D
Read More
Agouron's new MMP inhibitors described in patent literature
Read More
Dopamine D3 antagonists for psychoses and other D3 ligands designed at SmithKline Beecham
Read More
Seretide cleared for marketing in most E.U. countries
Read More
Novel, synthetic ultrasound contrast agent for echocardiography advances to clinical trials
Read More
Polish authorities allow phase II testing of Multikine
Read More
VP22 increases the efficacy of suicide gene therapy in vivo
Read More
Amylin gears up for regulatory filing of pramlintide and presents new clinical data
Read More
Millennium and partners extend drug discovery alliances
Read More
Amylin files IND for antidiabetes drug and reports on feasibility of alternative delivery routes
Read More
Amantadine reverses adverse effects of neuroleptic drugs on sexual function in males
Read More
Restructuring and name change announced by VIMRx
Read More
Isis and Abbott establish antisense target validation partnership
Read More
Combination of lovastatin and acipimox for type II diabetes and mixed dyslipidemia
Read More
Avanir requests meeting with FDA regarding Lidakol
Read More
Rigel and Janssen enter drug discovery collaboration
Read More
Tianeptine, a 5-HT uptake enhancer, demonstrates excellent efficacy in asthma
Read More
Onyx expands ONYX-015 clinical trials in liver metastases of colorectal cancer
Read More
Synsorb Biotech establishes collaboration with Ocean for novel antibiotic therapies
Read More
FDA advisory panel recommends clarification of data for Zila's OraTest
Read More